ARS Pharmaceuticals, Inc. (SPRY) vs Tilray Brands, Inc. (TLRY)
A side-by-side comparison of ARS Pharmaceuticals, Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SPRY
ARS Pharmaceuticals, Inc.
$4.28HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
TLRY
Tilray Brands, Inc.
$3.81HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — SPRY vs TLRY
growth of $100 · dividends reinvested · last 6ySPRY -82.8% (-25.5%/yr)TLRY -95.7% (-40.8%/yr)SPRY compounded faster over this window
SPRY TLRY
SPRY vs TLRY: by the numbers
- •TLRY is the larger company ($426M vs $425M market cap).
- •Both run net losses; TLRY's is the smaller (-12.90% vs -184.24% net margin).
- •SPRY grew revenue faster over the past five years (36.43% vs 17.11% CAGR).
Metrics side by side
Valuation
| Metric | SPRY | TLRY |
|---|---|---|
| P/S ratio | 3.64 | 0.37 |
| P/B ratio | 33.98 | 0.26 |
| EV / EBITDA | N/A | 23.00 |
Profitability
| Metric | SPRY | TLRY |
|---|---|---|
| Gross margin | 73.89% | 27.57% |
| Operating margin | -212.92% | -5.18% |
| Net margin | -184.24% | -12.90% |
| ROE | -1721.80% | -9.23% |
| ROIC | -114.65% | -2.98% |
Growth (annualized)
| Metric | SPRY | TLRY |
|---|---|---|
| Revenue CAGR (5Y) | 36.43% | 17.11% |
| Total return CAGR (5Y) | -16.35% | -49.30% |
Frequently asked
- Which has grown faster, SPRY or TLRY?
- Over the past five years, SPRY grew revenue faster — SPRY at a 36.43% CAGR versus TLRY at 17.11%.
- How have SPRY and TLRY total returns compared?
- Over the past 5 years, SPRY delivered -16.35% and TLRY delivered -49.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ARS Pharmaceuticals ROETilray Brands ROEARS Pharmaceuticals operating marginTilray Brands operating marginARS Pharmaceuticals revenue growthTilray Brands revenue growthARS Pharmaceuticals free cash flowTilray Brands free cash flow
ARS Pharmaceuticals & Tilray Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.